Note 11 - Stock-based Compensation

6 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

(11) Stock-Based Compensation

Stock Option Activity Summary

The Company’s stock option activity for the six months ended December 31, 2022 is as follows:

	Shares			Weighted Average Exercise Price
Outstanding at June 30, 2022		34,284		$	40.41
Granted		5,162			13.20
Exercised		—			—
Canceled or expired		(2,414	)		174.08
Outstanding at December 31, 2022		37,032		$	27.91

The aggregate intrinsic value of options exercisable at December 31, 2022 was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $446 thousand related to stock options will be recognized over a weighted-average period of 2.33 years.

The table below details the Company’s stock options outstanding as of December 31, 2022:

Range of exercise prices		Number Outstanding		Options Outstanding Weighted-Average Remaining Contractual Life (Years)		Weighted-Average Exercise Price		Number Exercisable		Options Exercisable Weighted-Average Exercise Price
$	13.20 - 19.20		34,361		9.35	$	18.30		—	$	—
$	55.50 - 84.90		431		5.76		62.22		431		62.22
$	159.00 - 175.50		2,240		4.36		168.82		2,240		168.82
$	13.20 - 175.50		37,032		9.00	$	27.91		2,671	$	151.62

Compensation costs recognized related to stock option awards were $48 thousand and $0 for each of the three months ended December 31, 2022, and 2021. Compensation costs recognized related to stock option awards were $94 thousand and $1 thousand for each of the six months ended December 31, 2022 and 2021.

Restricted Stock

The Company’s restricted stock activity for the six months ended December 31, 2022, is as follows:

	Shares		Weighted Average Grant Date Fair Value
Outstanding at June 30, 2022	75,873		$	39.00
Granted	—			—
Vested	—			—
Canceled or expired	(55	)		60.60
Outstanding at December 31, 2022	75,818		$	38.93

Stock compensation expenses related to restricted stock were $356 thousand and $439 thousand for the three months ended December 31, 2022, and 2021, respectively. Stock compensation expenses related to restricted stock were $697 thousand and $797 thousand for the six months ended December 31, 2022 and 2021, respectively. The remaining stock-based compensation expense of $2.0 million related to restricted stock awards granted will be recognized over a weighted-average period of 2.13 years.